GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Cyclically Adjusted PB Ratio

BioLife Solutions (STU:BJX1) Cyclically Adjusted PB Ratio : 4.53 (As of May. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Cyclically Adjusted PB Ratio?

As of today (2024-05-15), BioLife Solutions's current share price is €18.90. BioLife Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €4.17. BioLife Solutions's Cyclically Adjusted PB Ratio for today is 4.53.

The historical rank and industry rank for BioLife Solutions's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:BJX1' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.28   Med: 7.77   Max: 242.89
Current: 4.98

During the past years, BioLife Solutions's highest Cyclically Adjusted PB Ratio was 242.89. The lowest was 2.28. And the median was 7.77.

STU:BJX1's Cyclically Adjusted PB Ratio is ranked worse than
76.34% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs STU:BJX1: 4.98

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioLife Solutions's adjusted book value per share data for the three months ended in Mar. 2024 was €6.713. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioLife Solutions Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioLife Solutions's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Cyclically Adjusted PB Ratio Chart

BioLife Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 100.96 21.64 5.82 3.73

BioLife Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.27 5.83 3.37 3.73 4.12

Competitive Comparison of BioLife Solutions's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Cyclically Adjusted PB Ratio falls into.



BioLife Solutions Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioLife Solutions's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=18.90/4.17
=4.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLife Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BioLife Solutions's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.713/129.4194*129.4194
=6.713

Current CPI (Mar. 2024) = 129.4194.

BioLife Solutions Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.820 100.560 1.055
201409 0.816 100.428 1.052
201412 0.792 99.070 1.035
201503 0.827 99.621 1.074
201506 0.735 100.684 0.945
201509 0.670 100.392 0.864
201512 0.627 99.792 0.813
201603 0.534 100.470 0.688
201606 0.482 101.688 0.613
201609 0.430 101.861 0.546
201612 0.233 101.863 0.296
201703 0.201 102.862 0.253
201706 0.460 103.349 0.576
201709 0.454 104.136 0.564
201712 0.608 104.011 0.757
201803 0.600 105.290 0.738
201806 1.045 106.317 1.272
201809 2.064 106.507 2.508
201812 0.693 105.998 0.846
201903 2.098 107.251 2.532
201906 2.167 108.070 2.595
201909 3.435 108.329 4.104
201912 1.878 108.420 2.242
202003 2.897 108.902 3.443
202006 3.617 108.767 4.304
202009 4.937 109.815 5.818
202012 5.106 109.897 6.013
202103 5.214 111.754 6.038
202106 9.255 114.631 10.449
202109 10.034 115.734 11.220
202112 10.117 117.630 11.131
202203 10.264 121.301 10.951
202206 9.170 125.017 9.493
202209 9.655 125.227 9.978
202212 8.027 125.222 8.296
202303 7.726 127.348 7.852
202306 7.482 128.729 7.522
202309 7.098 129.860 7.074
202312 6.855 129.419 6.855
202403 6.713 129.419 6.713

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioLife Solutions  (STU:BJX1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioLife Solutions Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions (STU:BJX1) Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

BioLife Solutions (STU:BJX1) Headlines

No Headlines